Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis

European Journal of Immunology

Volumn 43, Issue 1, 2013, Pages 115-124

  Wang, Xu ^a   Haroon, Fahad ^a,d   Karray, Saoussen ^b   Martina Deckert, ^c   Schlüter, Dirk ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITY OF COLOGNE   (Germany)

^d HAMDARD UNIVERSITY   (India)

Author keywords

Astrocytes; Autoimmunity; EAE; FasL

Indexed keywords

CASPASE 3; FAS LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATION; IMMUNIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; ASTROCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FAS LIGAND PROTEIN; FORKHEAD TRANSCRIPTION FACTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, REGULATORY;

EID: 84872497437     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242679     Document Type: Article

References (46)

1. McFarland, H. F. and Martin, R., Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007. 8: 913-919.
2. Baxter, A. G., The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 2007. 7: 904-912.
3. Lees, J. R., Golumbek, P. T., Sim, J., Dorsey, D. and Russell, J. H., Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 2008. 205: 2633-2642.
4. Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A. and Goverman, J. M., Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 2008. 14: 337-342.
5. Kang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L. et al., Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 2010. 32: 414-425.
6. Domingues, H. S., Mues, M., Lassmann, H., Wekerle, H. and Krishnamoorthy, G., Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS ONE 2010. 5: e15531.
7. Codarri, L., Gyulveszi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T. et al., RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011. 12: 560-567.
8. Gold, R., Linington, C. and Lassmann, H., Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006. 129: 1953-1971.
9. Schmied, M., Breitschopf, H., Gold, R., Zischler, H., Rothe, G., Wekerle, H. and Lassmann, H., Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 1993. 143: 446-452.
10. Strasser, A., Jost, P. J. and Nagata, S., The many roles of FAS receptor signaling in the immune system. Immunity 2009. 30: 180-192.
11. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R. and Ferguson, T. A., Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995. 270: 1189-1192.
12. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A. and Duke, R. C., A role for CD95 ligand in preventing graft rejection. Nature 1995. 377: 630-632.
13. Hunt, J. S., Vassmer, D., Ferguson, T. A. and Miller, L., Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 1997. 158: 4122-4128.
14. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992. 356: 314-317.
15. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994. 76: 969-976.
16. Waldner, H., Sobel, R. A., Howard, E. and Kuchroo, V. K., Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 1997. 159: 3100-3103.
17. Zhu, B., Luo, L., Chen, Y., Paty, D. W. and Cynader, M. S., Intrathecal Fas ligand infusion strengthens immunoprivilege of central nervous system and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 2002. 169: 1561-1569.
18. Pender, M. P., Nguyen, K. B., McCombe, P. A. and Kerr, J. F., Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 1991. 104: 81-87.
19. Tabi, Z., McCombe, P. A. and Pender, M. P., Apoptotic elimination of V beta 8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of V beta 8.2 +encephalitogenic T cells. Eur. J. Immunol. 1994. 24: 2609-2617.
20. Sabelko-Downes, K. A., Cross, A. H. and Russell, J. H., Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 1999. 189: 1195-1205.
21. Bechmann, I., Steiner, B., Gimsa, U., Mor, G., Wolf, S., Beyer, M., Nitsch, R. et al., Astrocyte-induced T-cell elimination is CD95 ligand dependent. J. Neuroimmunol. 2002. 132: 60-65.
22. Kohji, T. and Matsumoto, Y., Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis. J. Neuroimmunol. 2000. 106: 165-171.
23. Haroon, F., Drögemüller, K., Händel, U., Brunn, A., Reinhold, D., Nishanth, G., Mueller, W. et al., Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation. J. Immunol. 2011. 186: 6521-6531.
24. Elliott, J. I., Surprenant, A., Marelli-Berg, F. M., Cooper, J. C., Cassady-Cain, R. L., Wooding, C., Linton, K. et al., Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat. Cell Biol. 2005. 7: 808-816.
25. Trajkovic, V., Vuckovic, O., Stosic-Grujicic, S., Miljkovic, D., Popadic, D., Markovic, M., Bumbasirevic, V. et al., Astrocyte-induced Treg cells mitigate CNS autoimmunity. Glia 2004. 47: 168-179.
26. Gultner, S., Kuhlmann, T., Hesse, A., Weber, J. P., Riemer, C., Baier, M. and Hutloff, A., Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE. Eur. J. Immunol. 2010. 40: 3403-3412.
27. Tsakiri, N., Papadopoulos, D., Denis, M. C., Mitsikostas, D. D. and Kollias, G., TNFR2 on non-haematopoietic cells is required for Foxp3 +Treg-cell function and disease suppression in EAE. Eur. J. Immunol. 2012. 42: 403-412.
28. Petermann, F. and Korn, T., Cytokines and effector T-cell subsets causing autoimmune CNS disease. FEBS Lett. 2011. 585: 3747-3757.
29. Fitzgerald, D. C., Zhang, G. X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. et al., Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 2007. 8: 1372-1379.
30. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. et al., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566-573.
31. Kobayashi, T., Okamoto, S., Hisamatsu, T., Kamada, N., Chinen, H., Saito, R., Kitazume, M. T. et al., IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008. 57: 1682-1689.
32. Giraud, S. N., Caron, C. M., Pham-Dinh, D., Kitabgi, P. and Nicot, A. B., Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. Proc. Natl. Acad. Sci. USA 2010. 107: 8416-8421.
33. Zhou, Y., Sonobe, Y., Akahori, T., Jin, S., Kawanokuchi, J., Noda, M., Iwakura, Y. et al., IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J. Immunol. 2011. 186: 4415-4421.
34. Toft-Hansen, H., Fuchtbauer, L. and Owens, T., Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 2011. 59: 166-176.
35. Voskuhl, R. R., Peterson, R. S., Song, B., Ao, Y., Morales, L. B., Tiwari-Woodruff, S. and Sofroniew, M. V., Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 2009. 29: 11511-11522.
36. Drögemüller, K., Helmuth, U., Brunn, A., Sakowicz-Burkiewicz, M., Gutmann, D. H., Mueller, W., Deckert, M. et al., Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J. Immunol. 2008. 181: 2683-2693.
37. van, L. G., De, L. R., Schmidt, H., Huth, M., Mildner, A., Schmidt-Supprian, M., Lassmann, H. et al., Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 2006. 7: 954-961.
38. Brambilla, R., Persaud, T., Hu, X., Karmally, S., Shestopalov, V. I., Dvoriantchikova, G., Ivanov, D. et al., Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 2009. 182: 2628-2640.
39. Meiron, M., Zohar, Y., Anunu, R., Wildbaum, G. and Karin, N., CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific Treg cells. J. Exp. Med. 2008. 205: 2643-2655.
40. Bajenaru, M. L., Zhu, Y., Hedrick, N. M., Donahoe, J., Parada, L. F. and Gutmann, D. H., Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol. Cell Biol. 2002. 22: 5100-5113.
41. Karray, S., Kress, C., Cuvellier, S., Hue-Beauvais, C., Damotte, D., Babinet, C. and Levi-Strauss, M., Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J. Immunol. 2004. 172: 2118-2125.
42. + T cell-mediated immune responses in murine Listeria monocytogenes meningoencephalitis. Eur. J. Immunol. 1995. 25: 2384-2391.
43. Frei, K., Bodmer, S., Schwerdel, C. and Fontana, A., Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages. J. Immunol. 1986. 137: 3521-3527.
44. Lenz, G. and Avruch, J., Glutamatergic regulation of the p70S6 kinase in primary mouse neurons. J. Biol. Chem. 2005. 280: 38121-38124.
45. Schlüter, D., Löhler, J., Deckert, M., Hof, H. and Schwendemann, G., Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. J. Neuroimmunol. 1991. 31: 185-198.
46. Livak, K. J. and Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001. 25: 402-408.